ASCO Decision Aid Helps Physician-Investigators Attribute SAEs to a Drug
The ASCO Decision Aid appears to help physician-investigators and research staff accurately determine whether an SAE was related to an investigational drug.
General Oncology
Vaping Injuries Raise New Concerns About Medical Marijuana
Many recent vaping injuries have been linked to e-cigarette use of THC oils or other cannabis oil products, raising new concerns about patients with cancer who use the devices for medical marijuana.
Test of Vascular Function May Predict Solid-Tumor Cancer Risk
Reactive hyperemia peripheral arterial tonometry index ≤2.0 predicted incidence of solid-tumor cancer.
ASCO Opinion Poll: Americans’ Knowledge About Cancer
The results of a recent ASCO poll suggest that many adults are unsure how to reduce their cancer risk and do not know what sources of information to trust.
Tools for Assessing, Managing Elderly With Cancer for Malnutrition
This review discusses nutritional interventions and management of nutritional status in elderly patients with cancer.
Cancer Risk Halved With Bariatric Surgery-Linked Weight Loss
Hazard ratio 0.44 for incident cancer with loss of at least 20 to 35 versus <20 percent of total body weight.
Trial Finds No Clinical Benefit of Higher Dose of Bevacizumab for Hearing Loss in Neurofibromatosis Type 2
Raising the dose of bevacizumab does not appear to add clinical benefit for adult and pediatric patients with neurofibromatosis type 2 and hearing loss.
Exercise Should Be Prescribed to Cancer Survivors
Key stakeholders are urged to create the infrastructure and necessary cultural adaptations.
Number of Cancer Patients Using Gabapentinoids Up Since 2005
Authors say more long-term studies of risks, efficacy of gabapentinoids needed.
Ziextenzo, a Biosimilar to Neulasta, Receives FDA Approval
The FDA has approved Ziextenzo (pegfilgrastim-bmez; Sandoz), a biosimilar to Neulasta.
Next post in General Oncology
